ArticleFrontiers in pharmacology2022

Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children's Hospital.

Maria Sole Giurin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.